Captrust Financial Advisors Bio Path Holdings Inc Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$3.77 - $5.24 $942 - $1,310	250 New	250 $1,000
Q2 2021 Aug 16, 2021	SELL	$5.13 - $7.63 $1,282 - $1,907	-250 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.63 - $11.77 $907 - $2,942	250 New	250 $2,000
Q4 2019 Feb 14, 2020	SELL	$6.97 - $12.3 $1,742 - $3,075	-250 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$1.81 - $38.86 $8,597 - $184,585	-4,750 Reduced 95.0%	250 $5,000
Q4 2018 Feb 13, 2019	BUY	$3.2 - $12.8 $16,000 - $64,000	5,000 New	5,000 $1,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $7.3M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.